Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Equity Ratio: 2010-2024

Historic Equity Ratio for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2024 value amounting to 0.77.

  • Sunshine Biopharma's Equity Ratio fell 7.75% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year decrease of 7.75%. This contributed to the annual value of 0.77 for FY2024, which is 0.84% down from last year.
  • Sunshine Biopharma's Equity Ratio amounted to 0.77 in FY2024, which was down 0.84% from 0.78 recorded in FY2023.
  • Sunshine Biopharma's 5-year Equity Ratio high stood at 0.78 for FY2023, and its period low was -0.91 during FY2020.
  • For the 3-year period, Sunshine Biopharma's Equity Ratio averaged around 0.76, with its median value being 0.77 (2024).
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 669.70% in 2022, then fell by 0.84% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Equity Ratio (Yearly) stood at -0.91 in 2020, then spiked by 110.52% to 0.10 in 2021, then surged by 669.70% to 0.74 in 2022, then rose by 4.86% to 0.78 in 2023, then dropped by 0.84% to 0.77 in 2024.